开窗分支腔内主动脉修复术中上肢入路与全股动脉入路的前瞻性评估
本研究基于前瞻性非随机临床试验,在两家中心纳入2013至2022年间接受开窗分支腔内主动脉修复术(FB-EVAR)治疗复杂腹主动脉瘤和胸腹主动脉瘤的541例患者,比较全股动脉(TF)入路与上肢(UE)入路在靶动脉纳入中的结局。结果显示TF入路与早期脑血管事件和主要不良事件发生率降低相关,且手术时间缩短。
要点
- TF入路患者30天脑血管事件发生率为0%,UE组为2.7%(P = .035)。
- TF组主要不良事件发生率为9%,低于UE组的18%(P = .006)。
- TF入路与透视时间和手术时间缩短相关(各P < .05)。
核心结论
- 与UE入路相比,TF入路用于靶动脉纳入时与早期脑血管事件和主要不良事件发生率降低相关。
- 无论支架移植物设计类型如何,TF入路患者的手术时间均缩短。
研究设计与样本
- 前瞻性、非随机临床试验,纳入两家中心2013至2022年间连续接受FB-EVAR治疗复杂腹主动脉瘤和胸腹主动脉瘤的患者。
- 共541例患者(70%男性;平均年龄74 ± 8岁),纳入2107条肾-肠系膜靶动脉。
- TF入路175例(32%),UE入路366例(68%);其中TF组146例(83%)、UE组314例(86%)患者纳入4条及以上靶动脉。
- 对使用定向分支设计的患者进行了亚组分析。
主要发现
- TF入路使用比例从2013至2017年的8%增至2018至2020年的31%,2021至2022年达96%。
- 与UE组相比,TF组患者更可能为复杂腹主动脉瘤而非胸腹主动脉瘤(37% vs 24%;P = .002)。
- 两组技术成功率均为96%(P = .96)。
- 30天死亡率TF组为0.6%,UE组为1.4%(P = .67)。
- TF组无早期脑血管事件,UE组发生率为2.7%(P = .035);主要不良事件发生率TF组为9%,UE组为18%(P = .006)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Total transfemoral (TF) access has been increasingly used during fenestrated-branched endovascular aortic repair (FB-EVAR). However, it is unclear whether the potential decrease in the risk of cerebrovascular events is offset by increased procedural difficulties and other complications. The aim of this study was to compare outcomes of FB-EVAR using a TF vs upper extremity (UE) approach for target artery incorporation. METHODS: We analyzed the clinical data of consecutive patients enrolled in a prospective, nonrandomized clinical trial in two centers to investigate the use of FB-EVAR for treatment of complex abdominal aortic aneurysms (CAAA) and thoracoabdominal aortic aneurysms (TAAA) between 2013 and 2022. Patients were classified into TF or UE access group with a subset analysis of patients treated using designs with directional branches. End points were technical success, procedural metrics, 30-day cerebrovascular events defined as stroke or transient ischemic attack, and any major adverse events (MAEs). RESULTS: There were 541 patients (70% males; mean age, 74 ± 8 years) treated by FB-EVAR with 2107 renal-mesenteric TAs incorporated. TF was used in175 patients (32%) and UE in 366 patients (68%) including 146 (83%) TF and 314 (86%) UE access patients who had four or more TAs incorporated. The use of a TF approach increased from 8% between 2013 and 2017 to 31% between 2018 and 2020 and 96% between 2021 and 2022. Compared with UE access patients, TF access patients were more likely to have CAAAs (37% vs 24%; P = .002) as opposed to TAAAs. Technical success rate was 96% in both groups (P = .96). The use of the TF approach was associated with reduced fluoroscopy time and procedural time (each P < .05). The 30-day mortality rate was 0.6% for TF and 1.4% for UE (P = .67). There was no early cerebrovascular event in the TF group, but the incidence was 2.7% for UE patients (P = .035). The incidence of MAEs was also lower in the TF group (9% vs 18%; P = .006). Among 237 patients treated using devices with directional branches, there were no significant differences in outcomes except for a reduced procedural time for TF compared with UE access patients (P < .001). CONCLUSIONS: TF access was associated with a decreased incidence of early cerebrovascular events and MAEs compared with UE access for target artery incorporation. Procedural time was decreased in TF access patients irrespective of the type of stent graft design.
引用
- Mesnard T, Vacirca A, Baghbani A, et al. Prospective evaluation of upper extremity access and total transfemoral approach during fenestrated and branched endovascular repair. J Vasc Surg. 2023. PMID: 38141739. doi:10.1016/j.jvs.2023.12.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。